Medical Device and Diagnostic Industry (MD+DI)

Dexcom CEO Talks G8 CGM Sensor

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
Healio

Fully-implantable CGM receives FDA authorization for integration with insulin pumps

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing approval to allow the Eversense E3 CGM to be integrated with insulin delivery systems.
Healio

CGM may be beneficial for people without diabetes, but more research needed

Please provide your email address to receive an email when new articles are posted on . Continuous glucose monitoring may be able to identify healthy adults who are at risk for type 1 or type 2 ...
Business Wire

Eversense 365 Launches in the US: One Year. One CGM.

Manage diabetes and not CGM interruptions with the new Eversense 365 CGM system – the only One Year CGM that is designed to help minimize device frustrations Ascensia launches the world’s first One ...
Medscape

CGM Metrics May Not Reflect A1c in People Without Diabetes

Standard metrics generated by continuous glucose monitors (CGM), such as average glucose, time-in-range (TIR), and the glycemic management indicator (GMI), may not align with A1c in people who don’t ...